Incyte (INCY) News Today $84.61 +0.91 (+1.09%) Closing price 04:00 PM EasternExtended Trading$84.35 -0.26 (-0.31%) As of 07:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock INCY Latest News All Sources Trusted Sources MarketBeat Barchart Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 Time Period Incyte Corporation (INCY) Expands Precision Medicine with QIAGEN PartnershipAugust 29 at 2:51 PM | finance.yahoo.comIeq Capital LLC Buys 156,964 Shares of Incyte Corporation $INCYAugust 29 at 7:14 AM | marketbeat.comCan Incyte Deliver on 447% EPS Forecasts and Pipeline Hype?Analysts expect nearly 450% EPS growth in 2025, making execution on its core portfolio critical for sustaining the outperformance experienced so far YTD.August 29 at 7:14 AM | marketbeat.comIncyte Corporation $INCY Shares Purchased by Caisse DE Depot ET Placement DU QuebecAugust 29 at 6:04 AM | marketbeat.comKayne Anderson Rudnick Investment Management LLC Has $1.88 Million Stock Position in Incyte Corporation $INCYAugust 29 at 5:48 AM | marketbeat.comIncyte Corporation (NASDAQ:INCY) Receives $81.60 Consensus Price Target from AnalystsAugust 29 at 3:49 AM | americanbankingnews.comIncyte Corp. stock underperforms Thursday when compared to competitorsAugust 28 at 9:17 PM | marketwatch.comIncyte Corporation (INCY) Expands Precision Medicine with QIAGEN PartnershipAugust 28 at 6:31 AM | insidermonkey.comAPG Asset Management N.V. Sells 28,484 Shares of Incyte Corporation $INCYAugust 28 at 5:52 AM | marketbeat.comCredit Agricole S A Purchases 4,234 Shares of Incyte Corporation $INCYAugust 28 at 4:51 AM | marketbeat.comQuantbot Technologies LP Buys 9,044 Shares of Incyte Corporation $INCYAugust 28 at 4:41 AM | marketbeat.comIncyte Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)August 27 at 5:07 PM | businesswire.comIncyte Corporation (NASDAQ:INCY) Receives Consensus Rating of "Hold" from AnalystsAugust 27 at 2:31 AM | marketbeat.comAlphaQuest LLC Grows Position in Incyte Corporation $INCYAugust 26 at 5:31 AM | marketbeat.comIncyte Corporation $INCY Shares Purchased by Northern Trust CorpAugust 26 at 4:05 AM | marketbeat.comIncyte appoints Soni Basi chief human resources officerAugust 25, 2025 | msn.comIncyte Announces the Appointment of Soni Basi as Executive Vice President and Chief Human Resources OfficerAugust 25, 2025 | mms.businesswire.comIncyte Announces the Appointment of Soni Basi as Executive Vice President and Chief Human ...August 25, 2025 | gurufocus.comIncyte Announces the Appointment of Soni Basi as Executive Vice President and Chief Human Resources OfficerAugust 25, 2025 | businesswire.comKorea Investment CORP Raises Position in Incyte Corporation $INCYAugust 25, 2025 | marketbeat.comJPMorgan Chase & Co. Issues Positive Forecast for Incyte (NASDAQ:INCY) Stock PriceAugust 24, 2025 | marketbeat.comCapital Fund Management S.A. Reduces Stock Position in Incyte Corporation $INCYAugust 24, 2025 | marketbeat.comIncyte Corporation $INCY Shares Sold by Erste Asset Management GmbHAugust 24, 2025 | marketbeat.comHsbc Holdings PLC Buys 6,093 Shares of Incyte Corporation $INCYAugust 24, 2025 | marketbeat.comIncyte (NASDAQ:INCY) Stock Price Expected to Rise, JPMorgan Chase & Co. Analyst SaysAugust 24, 2025 | americanbankingnews.comKaufman Rossin Wealth LLC Makes New Investment in Incyte Corporation $INCYAugust 23, 2025 | marketbeat.comPartners Capital Investment Group LLP Purchases New Position in Incyte Corporation $INCYAugust 23, 2025 | marketbeat.comAlgert Global LLC Sells 6,478 Shares of Incyte Corporation $INCYAugust 23, 2025 | marketbeat.comAberdeen Group plc Raises Stock Position in Incyte Corporation $INCYAugust 23, 2025 | marketbeat.comIncyte’s Phase 3 Study on Pembrolizumab and Epacadostat: Key Insights for InvestorsAugust 22, 2025 | msn.com13 Analysts Have This To Say About IncyteAugust 22, 2025 | benzinga.comIncyte’s Phase 2 Study on Parsaclisib: A Potential Game-Changer for Lymphoma Treatment?August 22, 2025 | tipranks.comIncyte’s Phase 2 Study Completion: Impact on Metastatic Lung Cancer TreatmentAugust 22, 2025 | tipranks.comNovartis and Incyte’s Ruxolitinib Study: A Potential Game-Changer for Myelofibrosis TreatmentAugust 22, 2025 | tipranks.comIncyte’s Phase 3 Study Update: Pembrolizumab and Epacadostat in Metastatic Urothelial CarcinomaAugust 22, 2025 | tipranks.comJP Morgan Maintains Incyte (INCY) Rating, Raises Price Target to $73 | INCY Stock NewsAugust 22, 2025 | gurufocus.comIncyte Corporation $INCY Shares Sold by Candriam S.C.A.August 22, 2025 | marketbeat.comGroupama Asset Managment Purchases 7,486 Shares of Incyte Corporation $INCYAugust 22, 2025 | marketbeat.comState of New Jersey Common Pension Fund D Has $3.54 Million Stake in Incyte Corporation $INCYAugust 22, 2025 | marketbeat.comKovitz Investment Group Partners LLC Boosts Stock Position in Incyte Corporation $INCYAugust 22, 2025 | marketbeat.comIncyte’s Phase 1 Study Completion: A Potential Boost for Cancer Treatment InnovationsAugust 21, 2025 | tipranks.comIncyte’s Retifanlimab Study Update: A Potential Game-Changer in Cancer TreatmentAugust 21, 2025 | tipranks.comIncyte’s Latest Study on INCB086550: Key Insights for InvestorsAugust 21, 2025 | tipranks.comIncyte’s INCB054707 Study Completion: A New Hope for Hidradenitis Suppurativa?August 21, 2025 | tipranks.comIncyte’s B-Cell Lymphoma Study Completion: A Potential Boost for InvestorsAugust 21, 2025 | tipranks.comIncyte (NASDAQ:INCY) Hits New 52-Week High - Still a Buy?August 21, 2025 | marketbeat.comNorthwest & Ethical Investments L.P. Increases Stake in Incyte Corporation $INCYAugust 21, 2025 | marketbeat.comIncyte Corporation $INCY Shares Bought by BNP PARIBAS ASSET MANAGEMENT Holding S.A.August 20, 2025 | marketbeat.comAre Wall Street Analysts Predicting Incyte Stock Will Climb or Sink?August 20, 2025 | barchart.comCytokinetics Appoints James M. Daly to Board of DirectorsAugust 20, 2025 | quiverquant.comQ Get Incyte News Delivered to You Automatically Sign up to receive the latest news and ratings for INCY and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. INCY Media Mentions By Week INCY Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. INCY News Sentiment▼0.911.03▲Average Medical News Sentiment INCY News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. INCY Articles This Week▼3125▲INCY Articles Average Week Get the Latest News and Ratings for INCY and Related Stocks Enter your email address to receive the latest news and analysts' ratings for Incyte and its competitors. Sign Up View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Related Companies and Tools Related Companies AbbVie News Today Regeneron Pharmaceuticals News Today Alnylam Pharmaceuticals News Today Biogen News Today United Therapeutics News Today Neurocrine Biosciences News Today BioMarin Pharmaceutical News Today Exelixis News Today Madrigal Pharmaceuticals News Today Exact Sciences News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:INCY) was last updated on 8/29/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredBONUS GUIDE - Ben Stein Prepares For the Next Financial CrisisWith inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...Goldco Precious Metals | SponsoredThis is my Christian duty“This land I will give to you…” — a 4,000-year-old line from Genesis may hold the key to unlocking a $150 tril...Paradigm Press | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredAlex’s “Next Magnificent Seven” stocksThe original “Magnificent Seven” turned $7K into $1.18 million. Now, Alex Green has identified AI’s Next Ma...The Oxford Club | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredOut of 18,347 Cryptocurrencies... This is the ONLY OneThe Single Most Undervalued DeFi Protocol You've Never Heard Of If there's one cryptocurrency you should b...Crypto 101 Media | Sponsored“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Incyte Corporation Please log in to your account or sign up in order to add this asset to your watchlist. Share Incyte With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access